# COVID-19 Coagulopathy Extension Study

> **NCT05334615** · — · RECRUITING · sponsor: **University of Iowa** · enrollment: 180 (estimated)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05334615
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-21
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05334615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05334615, "COVID-19 Coagulopathy Extension Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05334615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*